Bone Cancer Drugs is Fastest Growing Segment Fueling Growth of Bone Cancer Drugs Market

 Bone cancer drugs are primarily used for treatment of bone cancer such as osteosarcoma and Ewing's sarcoma. Bone cancer drugs inhibit tumor growth by stopping or slowing the growth of cancer cells. These drugs act through different mechanisms such as inhibiting DNA synthesis, cell division or inducing cell death.

The global Bone Cancer Drugs Market is estimated to be valued at US$ 1,286.4 Mn or Million in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
 
Market key trends:
Bone cancer is one of the rare types of cancers. According to World Health Organization (WHO), osteosarcoma account for approximately 60% of primary bone cancers diagnosed globally each year, with 3,000 new cases reported annually in the United States. Rising prevalence of bone cancer is majorly fueling the growth of the bone cancer drugs market. For instance, according to Cancer Research UK, in 2018 there were 1,162 new bone cancer cases in the UK. Moreover, development of novel targeted therapies for treatment of bone cancer is also contributing to the market growth. For example, in 2017, FDA approved innovative drug Larotrectinib, under brand name Vitrakvi, to treat solid tumors with NTRK gene fusions without a known acquired resistance mutation, including bone sarcoma.

Segment Analysis
The global bone cancer drugs market is segmented based on type, therapy, end user, and geography. By type, the market is segmented into multiple myeloma, osteosarcoma, chondrosarcoma, Ewing's sarcoma, and others. The osteosarcoma segment accounts for the largest share owing to its higher prevalence as it is one of the most common types of bone cancer affecting children and young adults. By therapy, the market is segmented into targeted therapy, chemotherapy, and others. The targeted therapy segment dominates the market as precision medicines are proven to be more effective with lower side effects compared to conventional chemotherapy. By end user, the market is divided into hospitals, specialty clinics, and others. Hospitals represent a major share of the end-user segment due to availability of advanced treatment facilities.

Key Takeaways
The global bone cancer drugs market is expected to witness high growth, exhibiting CAGR of 5.2% over the forecast period, due to increasing prevalence of bone cancer worldwide. The market size for 2023 is US$ 1,286.4 Mn. Regionally, North America is largest and fastest growing market for bone cancer drugs owing to developed healthcare infrastructure and high healthcare spending in the US and Canada. Key players operating in the bone cancer drugs market are Advaxis, Inc., Cellectar Biosciences, Inc., OPKO Health, Inc., Pfizer Inc., Amgen Inc., Novartis AG, Eli Lilly and Company, Debiopharm Group, Merck & Co, Bayer AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical, F. Hoffmann-La Roche Ltd and Teva Pharmaceutical.

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management

Image
  Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the ocular surface characterized by lack of sufficient moisture and tear film instability. Common symptoms of dry eye include stingy or burning sensation in eyes and blurred vision.   Market Dynamics : The Dry Eye Disease Market is witnessing high growth owing to rising awareness about disease management and increasing number of people experiencing symptoms of dry eyes. According to the report, increasing usage of electronic devices and prolonged screen time is a major driver fueling the demand for dry eye treatments. Additionally, growing geriatric population worldwide who are more prone to dry eyes is also contributing to the market growth. Availability of various treatment options along with new product launches is further expected to boost the market during forecast period.   Increasing Prevalence of Dry Eye Disease is Driving Market Growth   One of the major market drive...
Read more